Computed Tomographic Assessment of Coronary Arteries in Patients Undergoing Stem Cell Therapy Following an Acute Myocardial Infarction

1. Finegold JA, Asaria P, Francis DP. Mortality from ischaemic heart disease by country, region, and age: statistics from World Health Organisation and United Nations. Int J Cardiol. 2013;168:934-945.10.1016/j.ijcard.2012.10.046381999023218570Search in Google Scholar

2. Lauer MS. Advancing cardiovascular research. Chest. 2012;141:500-505.10.1378/chest.11-2521327729522315116Search in Google Scholar

3. Bergmann O, Bhardwaj RD, Bernard S, et al. Evidence for cardiomyocyte renewal in humans. Science. 2009;324:98-102.10.1126/science.1164680299114019342590Search in Google Scholar

4. Segers VF, Lee RT. Stem-cell therapy for cardiac disease. Nature. 2008;451:937-942.10.1038/nature0680018288183Search in Google Scholar

5. Asahara T, Kalka C, Isner JM. Stem cell therapy and gene transfer for regeneration. Gene therapy. 2000;7:451-457.10.1038/sj.gt.330114210757017Search in Google Scholar

6. Borlongan CV, Glover LE, Tajiri N, Kaneko Y, Freeman TB. The great migration of bone marrow-derived stem cells toward the ischemic brain: therapeutic implications for stroke and other neurological disorders. Progress in neurobiology. 2011;95:213-228.10.1016/j.pneurobio.2011.08.005318516921903148Search in Google Scholar

7. Tendera M, Wojakowski W, Ruzyllo W, et al. Intracoronary infusion of bone marrow-derived selected CD34+ CXCR4+ cells and non-selected mononuclear cells in patients with acute STEMI and reduced ventricular ejection fraction: results of randomized, multicenter Myocardial Regeneration by Intracoronary Infusion of Selected Population of Stem Cells in Acute Myocardial Infarction (REGENT) Trial. Eur Heart J. 2009;30:1313-1321.10.1093/eurheartj/ehp07319208649Search in Google Scholar

8. Meyer GP, Wollert CK, Lotz J, et al. Intracoronary bone marrow cell transfer after myocardial infarction: 5 year follow-up from the randomized-controlled BOOST trial. Eur Heart J. 2009;30:2978-2984.10.1093/eurheartj/ehp37419773226Search in Google Scholar

9. Benedek I, Bucur O, Benedek T. Intracoronary Infusion of Mononuclear Bone Marrow-Derived Stem Cells is Associated with a Lower Plaque Burden After Four Years. J Atheroscle Thromb. 2013;21:216-229.Search in Google Scholar

10. Wollert KC, Drexler H. Cell therapy for the treatment of coronary heart disease: a critical appraisal. Nat Rev Cardiol. 2010;7:204-215.10.1038/nrcardio.2010.120177405Search in Google Scholar

11. Lau JF, Anderson SA, Adler E, Frank JA. Imaging approaches for the study of cell-based cardiac therapies. Nat Rev Cardiol. 2010;7:97-105.10.1038/nrcardio.2009.227284730820027188Search in Google Scholar

12. Beeres SL, Bengel FM, Bartunek J, et al. Role of imaging in cardiac stem cell therapy. J Am Coll Cardiol. 2007;49:1137-1148.10.1016/j.jacc.2006.10.07217367656Search in Google Scholar

13. Amado LC, Saliaris AP, Schuleri KH, et al. Cardiac repair with intramyocardial injection of allogeneic mesenchymal stem cells after myocardial infarction. Proc Natl Acad Sci U S A. 2005;102:11474-1179.10.1073/pnas.0504388102118357316061805Search in Google Scholar

14. Sayyed SH, Cassidy MM, Hadi MA. Use of multidetector computed tomography for evaluation of global and regional left ventricular function. J Cardiovasc Comput Tomogr. 2009;3:23-34.10.1016/j.jcct.2008.10.01619138579Search in Google Scholar

15. Assmus B, Honold J, Schächinger V, et al. Transcoronary transplantation of progenitor cells after myocardial infarction. N Engl J Med. 2006;355:1222-1232.10.1056/NEJMoa05177916990385Search in Google Scholar

16. Nyolczas N, Gyöngyösi M, Beran G, et al. Design and rationale for the Myocardial Stem Cell Administration After Acute Myocardial Infarction (MYSTAR) Study: a multicenter, prospective, randomized, single-blind trial comparing early and late intracoronary or combined (percutaneous intramyocardial and intracoronary) administration of non-selected autologous bone marrow cells to patients after acute myocardial infarction. Am Heart J. 2007;153:212.e1-e7.10.1016/j.ahj.2006.10.02717239678Search in Google Scholar

17. Voros S. What are the potential advantages and disadvantages of volumetric CT scanning? J Cardiovasc Comput Tomogr. 2009;3:67-70.Search in Google Scholar

18. Miller JM, Rochitte CE, Dewey M, et al. Diagnostic performance of coronary angiography by 64-row CT. N Engl J Med. 2008;359:2324-2336.10.1056/NEJMoa080657619038879Search in Google Scholar

19. Voros S, Rinehart S, Qian Z, et al. Coronary atherosclerosis imaging by coronary CT angiography: current status, correlation with intravascular interrogation and meta-analysis. JACC Cardiovasc Imaging. 2011;4:537-548.10.1016/j.jcmg.2011.03.00621565743Search in Google Scholar

20. Boogers MJ, Broersen A, van Velzen JE, et al. Automated quantification of coronary plaque with computed tomography: comparison with intravascular ultrasound using a dedicated registration algorithm for fusion-based quantification. Eur Heart J. 2012;33:1007-1016.10.1093/eurheartj/ehr46522285583Search in Google Scholar

21. Budoff MJ, Shaw LJ, Liu ST, et al. Long-term prognosis associated with coronary calcification: observations from a registry of 25,253 patients. J Am Coll Cardiol. 2007;49:1860-1870.10.1016/j.jacc.2006.10.07917481445Search in Google Scholar

22. Greenland P, LaBree L, Azen SP, Doherty TM, Detrano RC. Coronary artery calcium score combined with Framingham score for risk prediction in asymptomatic individuals. JAMA. 2004;291:210-215.10.1001/jama.291.2.21014722147Search in Google Scholar

23. Arbab-Zadeh A, Fuster V. The Myth of the “Vulnerable Plaque”: transitioning from a focus on individual lesions to atherosclerotic disease burden for coronary artery disease risk assessment. J Am Coll Cardiol. 2015;65:846-855.Search in Google Scholar

24. de Graaf MA, Broersen A, Kitslaar PH, et al. Automatic quantification and characterization of coronary atherosclerosis with computed tomography coronary angiography: cross-correlation with intravascular ultrasound virtual histology. Int J Cardiovasc Imaging. 2013;29:1177-1190.10.1007/s10554-013-0194-x23417447Search in Google Scholar

25. de Feyter PJ, Nieman K. CCTA to guide revascularization for high-risk CAD: a “cliff hanger”. Eur Heart J. 2012;33:3011-3013.10.1093/eurheartj/ehs37123117163Search in Google Scholar

26. Schuleri KH, Centola M, Choi SH, et al. CT for Evaluation of Myocardial Cell Therapy in Heart Failure. JACC Cardiovasc Imaging. 2011;4:1284-1293.10.1016/j.jcmg.2011.09.013324573822172785Search in Google Scholar

27. Schuleri KH, Feigenbaum GS, Centola M, et al. Autologous mesenchymal stem cells produce reverse remodelling in chronic ischaemic cardiomyopathy. Eur Heart J. 2009;30:2722-2732.10.1093/eurheartj/ehp265277702719586959Search in Google Scholar

28. Quevedo HC, Hatzistergos KE, Oskouei BN, et al. Allogeneic mesenchymal stem cells restore cardiac function in chronic ischemic cardiomyopathy via trilineage differentiating capacity. Proc Natl Acad Sci U S A. 2009;106:14022-14027.10.1073/pnas.0903201106272901319666564Search in Google Scholar

29. Amado LC, Schuleri KH, Saliaris AP, et al. Multimodality Noninvasive Imaging Demonstrates In Vivo Cardiac Regeneration After Mesenchymal Stem Cell Therapy. J Am Coll Cardiol. 2006;48:2116-2124.10.1016/j.jacc.2006.06.07317113001Search in Google Scholar

30. Orlic D, Kajstura J, Chimenti S, et al. Bone marrow cells regenerate infarcted myocardium. Nature. 2001;410:701-705.10.1038/3507058711287958Search in Google Scholar